Oppenheimer & Co. Inc. Has $602,000 Position in AptarGroup, Inc. (NYSE:ATR)

Posted by Defense World Staff on Feb 24th, 2023

Oppenheimer & Co. Inc. boosted its holdings in AptarGroup, Inc. (NYSE:ATR – Get Rating) by 13.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,334 shares of the industrial products company’s stock after purchasing an additional 742 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in AptarGroup were worth $602,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of ATR. Raymond James Financial Services Advisors Inc. grew its position in AptarGroup by 10.3% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 10,393 shares of the industrial products company’s stock valued at $1,221,000 after purchasing an additional 970 shares during the period. HighTower Advisors LLC boosted its holdings in AptarGroup by 6.3% during the 1st quarter. HighTower Advisors LLC now owns 6,976 shares of the industrial products company’s stock worth $820,000 after acquiring an additional 416 shares during the last quarter. Great West Life Assurance Co. Can boosted its holdings in AptarGroup by 9.1% during the 1st quarter. Great West Life Assurance Co. Can now owns 37,547 shares of the industrial products company’s stock worth $4,539,000 after acquiring an additional 3,125 shares during the last quarter. Raymond James Trust N.A. boosted its holdings in AptarGroup by 7.1% during the 1st quarter. Raymond James Trust N.A. now owns 4,632 shares of the industrial products company’s stock worth $545,000 after acquiring an additional 308 shares during the last quarter. Finally, Sei Investments Co. boosted its holdings in AptarGroup by 0.4% during the 1st quarter. Sei Investments Co. now owns 122,797 shares of the industrial products company’s stock worth $14,429,000 after acquiring an additional 484 shares during the last quarter. Institutional investors and hedge funds own 89.37% of the company’s stock.

Insider Activity at AptarGroup

In other news, Director Maritza Gomez Montiel sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 21st. The stock was sold at an average price of $114.67, for a total transaction of $172,005.00. Following the sale, the director now directly owns 4,024 shares in the company, valued at $461,432.08. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, CFO Robert Kuhn sold 64,560 shares of the company’s stock in a transaction dated Tuesday, February 21st. The stock was sold at an average price of $114.04, for a total transaction of $7,362,422.40. Following the sale, the chief financial officer now directly owns 54,044 shares in the company, valued at $6,163,177.76. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Maritza Gomez Montiel sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 21st. The shares were sold at an average price of $114.67, for a total value of $172,005.00. Following the sale, the director now owns 4,024 shares in the company, valued at $461,432.08. The disclosure for this sale can be found here. 1.20% of the stock is currently owned by company insiders.

AptarGroup Trading Down 0.1 %

Shares of AptarGroup stock opened at $114.56 on Friday. AptarGroup, Inc. has a 52-week low of $90.23 and a 52-week high of $122.94. The stock’s 50-day simple moving average is $112.00 and its 200 day simple moving average is $105.97. The stock has a market capitalization of $7.49 billion, a P/E ratio of 32.00, a P/E/G ratio of 4.30 and a beta of 0.63. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.03 and a current ratio of 1.56.

AptarGroup (NYSE:ATR – Get Rating) last announced its quarterly earnings data on Friday, February 17th. The industrial products company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.79 by $0.13. AptarGroup had a return on equity of 12.78% and a net margin of 7.20%. The business had revenue of $795.91 million for the quarter, compared to analysts’ expectations of $775.57 million. During the same period in the previous year, the business posted $0.93 EPS. The firm’s quarterly revenue was down 2.2% compared to the same quarter last year. As a group, research analysts anticipate that AptarGroup, Inc. will post 3.82 EPS for the current year.

AptarGroup Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 23rd. Investors of record on Thursday, February 2nd were paid a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend was Wednesday, February 1st. AptarGroup’s dividend payout ratio is currently 42.46%.

Analysts Set New Price Targets

A number of research firms have issued reports on ATR. StockNews.com downgraded shares of AptarGroup from a “buy” rating to a “hold” rating in a report on Monday. BMO Capital Markets assumed coverage on shares of AptarGroup in a report on Monday, October 31st. They set a “buy” rating and a $135.00 price objective on the stock. TheStreet upgraded AptarGroup from a “c+” rating to a “b-” rating in a research note on Tuesday, January 17th. Deutsche Bank Aktiengesellschaft lifted their target price on AptarGroup from $125.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Robert W. Baird lifted their target price on AptarGroup from $105.00 to $115.00 and gave the stock a “neutral” rating in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $122.33.

AptarGroup Profile

(Get Rating)

AptarGroup, Inc engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions and services for the prescription drug, consumer health care, injectables, active packaging, beauty, personal care, home care, and food and beverages. It operates through the following business segments: Beauty & Home, Pharma and Food & Beverage.

Institutional Ownership by Quarter for AptarGroup (NYSE:ATR)

Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.